Redefining Early Stage Investments (RESI)

When: September 26, 2017, 12:00 am - 11:59 pm

Redefining Early Stage Investments is an ongoing conference series for early stage life science companies to source investors, create relationships, and eventually, secure funding. These events will give early stage life science companies the chance to start or resume conversations with relevant investors in order to bring products to market at a faster pace. These conferences also provide an international venue, where LSN clients and partners dialogue with investors from around the globe.

Highlights:

• Full-day partnering conference that is focused on connecting early stage companies with active investors from 10 categories of investors

• One-to-one investor to company ratio

• In-depth panels featuring investors from 10 categories of early stage investors

• Opportunities for companies to present using poster-board presentations

• Potentially 16 face-to-face investor meetings per attendee (the previous RESI had over 700 meetings)

• Custom-built partnering system that is tailored to the early stage biotech and medtech investment arenas

• Meta-tagged investor profiles that offer pinpoint accuracy to executives looking for investors that are a fit

Learn more »

Connect With Us

Facebook LinkedIn Twitter